InsidersTradesSigma
Follow the 华恒生物 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 华恒生物 has recorded 1 reports. Market capitalisation: €4bn. The latest transaction was filed on 6 June 2025 (Sale). Among the most active insiders: 唐思青. Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€268,366
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,149 of 29,056 companies
33.6
score / 100
Value34
Quality34
FCF yld-13%
Earn yld3.3%
EV/EBITDA15.9x
ROE4.3%
Gross mgn21%
Net mgn4.6%
Debt/EBITDA5.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 June 2025
Acerca de 华恒生物
华恒生物 es una empresa del sector sanitario y farmacéutico, que cotiza en la Bolsa de Shanghái. Se centra en el desarrollo y la producción de productos biológicos y farmacéuticos.